Literature DB >> 2151900

Early ventricular remodeling after myocardial damage and its attenuation by converting enzyme inhibition.

K M McDonald1, P F Carlyle, J Matthews, K Hauer, T Elbers, D Hunter, J N Cohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2151900

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  4 in total

1.  Pharmacotherapy: inhibiting LV remodeling—the need for a targeted approach.

Authors:  Jay N Cohn
Journal:  Nat Rev Cardiol       Date:  2011-05       Impact factor: 32.419

Review 2.  Treatment of infarct related heart failure: vasodilators other than ACE inhibitors.

Authors:  J N Cohn
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

3.  Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies.

Authors:  Claudio Borghi; Stefano Omboni; Giorgio Reggiardo; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Journal:  J Cardiovasc Pharmacol       Date:  2017-01       Impact factor: 3.105

4.  Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.

Authors:  Katarzyna A Mitręga; Adrianna M Spałek; Jerzy Nożyński; Maurycy Porc; Magdalena Stankiewicz; Tadeusz F Krzemiński
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.